‘Bath Salts’: The Ever-Changing Landscape of Synthetic Cathinones
Tuesday April 24, 2018
9:30 am
-
12:00 pm
Eastern Time (ET)
Room 16B
BEH
TOX
Chair :
Michael Taffe
Scripps Research Institute
Stephen Kohut
Harvard Medical School
Sponsored by La Jolla Alcohol Research, Inc.
The use of novel cathinone analogs, popularly referred to as ‘bath salts,’ has emerged as a substance abuse problem in the US in recent years. These substances are produced and distributed by clandestine markets in an attempt to circumvent their status as illegal substances. New synthetic cathinones that differ slightly in chemical structure and pharmacology from previous analogs, continue to show up in confiscated samples at an alarming rate. Synthetic cathinones share many of the neurochemical effects of psychomotor stimulants such as methamphetamine, cocaine, or MDMA, but differ on a range of behavioral and physiological endpoints.
Speakers
Richard Glennon
- Virginia Commonwealth University
Structure-Activity Relationships of 'Bath Salt' Constituents
Michael Gatch
- University of North Texas Health Science Center
In Vivo Pharmacology of Novel Synthetic Cathinones
Jacques Nguyen
- Scripps Research Institute
Locomotor Stimulant and Rewarding Effects of Inhaled 'Bath Salts'
Annette Fleckenstein
- University of Utah
Neurochemical Deficits Induced by Synthetic Cathinones
Gregory Collins
- University of Texas Health Science Center at San Antonio
Reinforcing Effects of Novel Synthetic Cathinones and Their Mixtures
Samantha McClenahan
- University of Arkansas for Medical Sciences
Development and Preclinical Testing of a Vaccine for 3,4-Methylenedioxypyrovalerone ((R,S)-MDPV) Substance Use Disorders